Surrozen (SRZN) Non-cash Items (2021 - 2026)
Surrozen (SRZN) recorded quarterly Non-cash Items of $23.0 million in Q1 2026, up 78.49% quarter-over-quarter from $12.9 million in Q4 2025, and up 3442.9% on a YoY basis from $648000.0 in Q1 2025.
Surrozen (SRZN) Non-cash Items (2021 - 2026) Analysis & Trends
Surrozen's Non-cash Items history runs 6 years deep, the most recent figure standing at $23.0 million for Q1 2026.
- In Q1 2026, Non-cash Items rose 3442.9% year-over-year to $23.0 million; the TTM figure through Mar 2026 stood at $23.0 million (up 3442.9% YoY), while the FY2025 annual figure was $12.9 million, up 4909060.31% from the prior year.
- Non-cash Items was $23.0 million for Q1 2026 at Surrozen, up from $12.9 million in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $23.0 million in Q1 2026 to a low of $262.0 in Q4 2024.
- Historically, Non-cash Items has averaged $2.6 million across 5 years, with a median of $228000.0 in 2024.
- The sharpest annual moves came in 2022 and 2025: Non-cash Items slumped 99.96% in 2022, then jumped 4909060.31% in 2025.
- A 5-year view of Non-cash Items shows it stood at $1430.0 in 2022, then surged by 1858.04% to $28000.0 in 2023, then plunged by 99.06% to $262.0 in 2024, then surged by 4909060.31% to $12.9 million in 2025, then surged by 78.49% to $23.0 million in 2026.
- The last three Non-cash Items figures came in at $23.0 million (Q1 2026), $12.9 million (Q4 2025), and $418000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Surrozen | 225,877.86 | -106.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.96 Mn |
| Mar 31, 2026 | 22.96 Mn |
| Dec 31, 2025 | 12.86 Mn |
| Dec 31, 2025 | 12.86 Mn |
| Sep 30, 2025 | 418,000.00 |
| Sep 30, 2025 | 418,000.00 |
| Jun 30, 2025 | 36,000.00 |
| Jun 30, 2025 | 36,000.00 |
| Mar 31, 2025 | 648,000.00 |
| Mar 31, 2025 | 648,000.00 |
| Dec 31, 2024 | 262.00 |
| Dec 31, 2024 | 262.00 |
| Sep 30, 2024 | 240,000.00 |
| Sep 30, 2024 | 240,000.00 |
| Jun 30, 2024 | 216,000.00 |
| Jun 30, 2024 | 216,000.00 |
| Mar 31, 2024 | 310,000.00 |
| Mar 31, 2024 | 310,000.00 |
| Dec 31, 2023 | 28,000.00 |
| Dec 31, 2023 | 28,000.00 |